Spectrum Pharmaceuticals Inc NTR-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:09 AM CET
0.7416quote price arrow up+0.0115 (+1.58%)
52 week range
0.26 - 1.55
Loading...
  • Open0.7416
  • Day High0.7416
  • Day Low0.7416
  • Prev Close0.7413
  • 52 Week High1.55
  • 52 Week High Date08/16/22
  • 52 Week Low0.26
  • 52 Week Low Date12/29/22

Key Stats

  • Market Cap164.71M
  • Shares Out203.34M
  • 10 Day Average Volume2,125
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change140.08

KEY STATS

  • Open0.7416
  • Day High0.7416
  • Day Low0.7416
  • Prev Close0.7413
  • 52 Week High1.55
  • 52 Week High Date08/16/22
  • 52 Week Low0.26
  • 52 Week Low Date12/29/22
  • Market Cap164.71M
  • Shares Out203.34M
  • 10 Day Average Volume2,125
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change140.08

RATIOS/PROFITABILITY

  • EPS (TTM)-0.63
  • P/E (TTM)-1.18
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spectrum Pharmaceuticals Inc

 

Profile

MORE
Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a...
William Ashton
Non-Executive Independent Chairman of the Board
Thomas Riga
President, Chief Executive Officer, Director
Nora Brennan
Chief Financial Officer, Director
Keith Mcgahan
Executive Vice President, Chief Legal Officer, Corporate Secretary
Address
11500 S Eastern Ave Ste 240
Henderson, NV
89052-5576
United States